Phase I/II study of CA IX imaging and therapy in renal cell carcinoma
Автор: VJOncology
Загружено: 2026-03-16
Просмотров: 8
Описание:
Michael Hofman, FRACP, MBBS, Peter MacCallum Cancer Centre, Melbourne, Australia, discusses a Phase I/II study (NCT05706129) of a peptidomimetic theranostic pair targeting carbonic anhydrase IX (CA IX). The trial assesses safety and efficacy of imaging with [68Ga]Ga-DPI-4452 and therapy with [177Lu]Lu-DPI-4452 in advanced clear cell renal cell carcinoma. Additionally, the study explores diagnostic concordance in patients with indeterminate renal masses. This interview took place at the 2026 ASCO GU Cancers Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
![Эффект Джанибекова [Veritasium]](https://imager.clipsaver.ru/N9HlQ-XVnFk/max.jpg)
